Arbor Pharmaceuticals Inc. FDA Inspection Record

FEI 3006411608 · Inspections, Form 483s, warning letters and import refusals

Arbor Pharmaceuticals Inc. is an FDA-inspected facility (FEI 3006411608) located in Atlanta, GA, US. RegDataLab tracks 4 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Oct 15, 2021: No Action Indicated (NAI)
Inspections on record
4 (1 VAI, 3 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
5, latest Sep 16, 2020

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Oct 15, 2021No Action Indicated (NAI)No citations listed
Jan 28, 2016No Action Indicated (NAI)No citations listed
Aug 16, 2012No Action Indicated (NAI)No citations listed
Aug 27, 2010Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Written program not followed (21 CFR 211.166(a))
Procedures to be written and followed (21 CFR 211.198(a))

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Sep 16, 2020Class IIID-1625-2020Nymalize (nimodipine) oral solution, 60 mg/20 mL, 12 Unit-Dose Cups and 12 Oral Syringes…
Subpotent Drug
Sep 27, 2019Class IIID-0167-2020Testosterone Cypionate Injection, USP, 2000 mg/10 mL, 1 mL Vial, Single-Dose, Rx only…
Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose vials, found to contain…
Jul 21, 2016Class ID-0105-2017Cetylev (acetylcysteine) effervescent tablets for oral solution, 500 mg, Rx Only, 20…
Defective Container: Incomplete seal on blister packaging, leading to tablet swelling and enlarging due to effervescence process beginning…
Apr 20, 2011Class IIID-705-2011Fluor-A-Day Chewable Tablets (Sodium Fluoride, USP & Xylitol), 1.0mg F, 236.79 mg Xylitol…
Labeling; Label Error on Declared Strength; label incorrectly states that the tablets are quarter strength and (1.1mg sodium fluoride) but…
Oct 13, 2010Class IID-093-2011Zinotic ES (Chloroxylenol 0.1%, Pramoxine HCl 1.0%, Zinc Acetate Dihydrate 1.0%, Otic…
Impurities/Degradation Products: The affected batches, during stability testing, yielded results higher than acceptable levels of…

FDA record score

0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

3 records behind this number
RecordDatePoints x age weightAdds
Class I recall D-0105-2017, this FEI as the recalling firmJul 21, 201610 years or older, so it adds no points0
Class II recall D-093-2011, this FEI as the recalling firmOct 13, 201010 years or older, so it adds no points0
Inspection classified VAIAug 27, 201010 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Arbor Pharmaceuticals Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Arbor Pharmaceuticals Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Arbor Pharmaceuticals Inc.
Location
Atlanta, GA (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.